Awards & GrantsFeaturedFeatured EUNF1NF2-SWNPress ReleaseScience & ResearchSWN 8 Bold Minds, $888K to Fuel the Future of NF Research
FeaturedFeatured EUNF1PharmaPress Release FDA Grants Priority Review to SpringWorks Therapeutics’ New Drug for NF1 Patients
Press ReleaseSpecial EventsWays to Give ‘Dancing with Our Stars’ Gala Returns to the Wally Allen Ballroom to Raise Money for Rare Genetic Disorder
FeaturedGlobalNF ConferencePress ReleaseScience & ResearchTop Story EU Children’s Tumor Foundation Europe Leads Collective Effort in Accelerating Therapeutics and Innovation for Rare Diseases
Collaborations & PartnershipsNF2-SWNPress ReleasePublicationsScience & ResearchTop StoryTop Story EU Brigatinib Shows Promise for NF2-SWN: A Direct Result of CTF’s Synodos Initiative
GlobalNF ConferenceNF1NF2-SWNPress ReleaseScience & ResearchSWNTop StoryTop Story EU Children’s Tumor Foundation Presents the 2024 Global NF Conference in Brussels: Shaping What’s Next for NF
Featured EUPress Release Welcome Dariusz Adamczewski as Managing Director of Children’s Tumor Foundation Europe
AwarenessFeaturedFeatured EUPress Release Global Landmarks Illuminate for World NF Awareness Day as Children’s Tumor Foundation Highlights its Make NF Research Visible Campaign
Collaborations & PartnershipsFeaturedFeatured EUPress ReleaseScience & ResearchSWN Revolutionary Partnership Drives Breakthrough Research Investigation into Schwannomatosis